Nabriva Gets Initial Nod For $3M Investor Settlement
By Emilie Ruscoe · January 29, 2021, 2:07 PM EST
A Manhattan federal judge gave an initial nod to a $3 million settlement that would end investor claims that biopharmaceutical company Nabriva Therapeutics PLC and four of its executives misrepresented the...
To view the full article, register now.